| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/2009 | CN101365701A 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors |
| 02/11/2009 | CN101365700A Azaindazoles useful as inhibitors of kinases |
| 02/11/2009 | CN101365699A Pyrido(3,2-D)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 02/11/2009 | CN101365698A 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 02/11/2009 | CN101365697A Tetomilast polymorphs |
| 02/11/2009 | CN101365696A Compounds and compositions as modulators of steroid hormone nuclear receptors |
| 02/11/2009 | CN101365695A Quinazoline derivatives as anticancer agents |
| 02/11/2009 | CN101365694A Heterocycle-substituted 3-alkyl azetidine derivatives |
| 02/11/2009 | CN101365693A Selected CGRP antagonists, methods for the production thereof and their use as medicaments |
| 02/11/2009 | CN101365692A Novel antifungal triazole derivatives |
| 02/11/2009 | CN101365690A Biphenyl derivatives as modulators of voltage gated ion channels |
| 02/11/2009 | CN101365689A 1,3-oxazolidin-2-one derivatives useful as cetp inhibitors |
| 02/11/2009 | CN101365686A Heterocyclic derivatives as modulators of ion channels |
| 02/11/2009 | CN101365685A 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the TRPV1 receptor |
| 02/11/2009 | CN101365684A Indazole derivatives that inhibit trpv1 receptor |
| 02/11/2009 | CN101365677A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 02/11/2009 | CN101365674A Interleukin-1 and tumor necrosis factor-a modulators, syntheses of such modulators and methods of using such modulators |
| 02/11/2009 | CN101365671A Isohumulone compound clathrate and composition containing the same |
| 02/11/2009 | CN101365512A Bisphosphonate formulation |
| 02/11/2009 | CN101365487A Method for treating joint damage |
| 02/11/2009 | CN101365476A Combined use of dpp iv inhibitors and gastrin compounds |
| 02/11/2009 | CN101365465A Composition comprising liquiritigenin for preventing and treating liver disease |
| 02/11/2009 | CN101365462A Microbicidal dendrimer composition delivery system |
| 02/11/2009 | CN101365461A Derivatives of sulindac, use thereof and preparation thereof |
| 02/11/2009 | CN101365460A Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
| 02/11/2009 | CN101365459A Sulfoalkyl ether cyclodextrin composite and preparation |
| 02/11/2009 | CN101365458A Methods and compositions for administration of iron |
| 02/11/2009 | CN101365457A Practical, cost-effective synthesis of ubiquinones |
| 02/11/2009 | CN101365456A Method for treating primary and secondary forms of glaucoma |
| 02/11/2009 | CN101365455A Uses of rifamycins |
| 02/11/2009 | CN101365454A Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/11/2009 | CN101365453A Dipyridamole extended-release formulations and process for preparing same |
| 02/11/2009 | CN101365452A Methods and compositions for the treatment of vascular disease |
| 02/11/2009 | CN101365451A Methods of using small molecule compounds for neuroprotection |
| 02/11/2009 | CN101365450A Stable pharmaceutical formulations of montelukast sodium |
| 02/11/2009 | CN101365449A Nanoparticulate benzothiophene formulations |
| 02/11/2009 | CN101365448A Compositions containing opioid antagonists |
| 02/11/2009 | CN101365447A Pharmaceuticals compositions containing nanomaterials useful for treating restenotic lesions |
| 02/11/2009 | CN101365446A Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 02/11/2009 | CN101365445A Treatment of length dependent neuropathy |
| 02/11/2009 | CN101365444A Immunomodulatory pharmaceutical composition containing a combination of three coumarinolignoids |
| 02/11/2009 | CN101365443A Antialergic agent, and food and drink, external preparation and cosmetic containing it |
| 02/11/2009 | CN101365442A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| 02/11/2009 | CN101365441A Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| 02/11/2009 | CN101365440A Methods of treating cancers with saha, carboplatin, and paclitaxel and other combination therapies |
| 02/11/2009 | CN101365439A Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 02/11/2009 | CN101365438A Composition for prevention of recurrence of stroke |
| 02/11/2009 | CN101365437A Compositions of cis-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof |
| 02/11/2009 | CN101365436A Methods of treating ischemic related conditions |
| 02/11/2009 | CN101365435A Combination of organic compounds |
| 02/11/2009 | CN101365434A Treatment of type 2 diabetes with a combination of DPIV inhibitor and metformin or thiazolidinedione |
| 02/11/2009 | CN101365433A Iontophoresis preparation |
| 02/11/2009 | CN101365432A Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 02/11/2009 | CN101365431A Novel use of nutraceutical compositions comprising resveratrol |
| 02/11/2009 | CN101365430A Adenosine a3 receptor agonists for the treatment of dry eye disorders |
| 02/11/2009 | CN101365425A Drug delivery system for bioadhesion to a vulvovaginal surface |
| 02/11/2009 | CN101365423A Sustained release small molecule drug formulation |
| 02/11/2009 | CN101363029A Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex DNA |
| 02/11/2009 | CN101362791A Steroidal alkaloid veratramine, preparation method thereof and antihypertensive application |
| 02/11/2009 | CN101362790A Starfish saponins antineoplastic compounds |
| 02/11/2009 | CN101362773A Heterocyclic boronic acid compounds |
| 02/11/2009 | CN101362765A 5,7-diaminopyrazolo '4,3-d!pyrimidines with PDE-5 inhibiting activity |
| 02/11/2009 | CN101362764A 5,7-diaminopyrazolo '4,3-d!pyrimidines with PDE-5 inhibiting activity |
| 02/11/2009 | CN101362763A Carbapenem derivates containing sulfhydryl pyrrolidine |
| 02/11/2009 | CN101362762A Penem compound containing sulfhydryl piperidine |
| 02/11/2009 | CN101362761A Carbapenem antibiotic containing sulfhydryl piperidine |
| 02/11/2009 | CN101362760A 1beta-methyl carbapenem compound |
| 02/11/2009 | CN101362759A Dihydropyrrole methano substituted carbapenem derivates |
| 02/11/2009 | CN101362758A Penem derivates containing sulfhydryl pyrrolidine vinyl heterocycle |
| 02/11/2009 | CN101362757A Sulfonyl substituted carbpenems compounds |
| 02/11/2009 | CN101362754A New compound of 13-methyl dehydro corydalmine and isolation and identification method thereof |
| 02/11/2009 | CN101362749A Sertindole synthesis method |
| 02/11/2009 | CN101362748A Method for preparing sertindole |
| 02/11/2009 | CN101362746A Separation method of argatroban single stereoisomers and polymorph |
| 02/11/2009 | CN101362744A Sialic acid analogue and application thereof in anti-influenza virus medicament |
| 02/11/2009 | CN101362737A 2-(4-substituted phenyl-1,2,3-thiadiazole-5sulfhydryl)-N-substituted phenyl acetamides derivates, preparation thereof and application |
| 02/11/2009 | CN101362736A Benzenesulfonamides Ca-4 analogue, synthesis method and application |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/11/2009 | CN101362725A Method for preparing tetramethylpyrazine guanidine derivatives and application thereof |
| 02/11/2009 | CN101362724A Tetramethylpyrazine acidamides derivates, preparation method and medicament composition and application |
| 02/11/2009 | CN101362722A N-substituted phenyl-2-(1-aryl-1H-imidazolyl-2-sulfhydryl) acetamides derivates, preparation method thereof and application |
| 02/11/2009 | CN101362719A Chinolines derivates and composition containing thereof |
| 02/11/2009 | CN101362718A 4-(4-benzamido phenoxy)-2-(methylcarbamoyl) pyridine derivatives, preparation method and application thereof |
| 02/11/2009 | CN101362717A 4-(4-amidoanilino)-2-(methylcarbamoyl) pyridine, derivates thereof and preparation, application thereof |
| 02/11/2009 | CN101362715A Preparation method of n-acetyl-5-methoxytryptamine |
| 02/11/2009 | CN101362702A Emodin derivates and application thereof in anti-cancer medicine preparation |
| 02/11/2009 | CN101362679A Antrodia camphoratea pimelie kelone compound for inhibiting B type hepatitis virus |
| 02/11/2009 | CN101361982A Preparation method of folacin coupled chitosan |
| 02/11/2009 | CN101361980A Heparin phospholipid composite suitable for non-injection administration and preparation method thereof |
| 02/11/2009 | CN101361978A Anti-cancer medicine release system using cellular membrane biomimetic modification polyamide-amide as carrier and preparation method thereof |
| 02/11/2009 | CN101361970A Composition with beauty effect and health care efficacy and use thereof |
| 02/11/2009 | CN101361959A Medicine for curing the dysmenorrhea |
| 02/11/2009 | CN101361956A Traditional Chinese medicine cataplasm for treating measles complicated pneumonia |
| 02/11/2009 | CN101361951A Skin external preparation with anti-inflammation, itching-relieving and disinfection and sterilization function and preparation method thereof |
| 02/11/2009 | CN101361950A Gynaecologic traditional Chinese medicine capable of dispelling coldness, promoting blood and alleviating pain and preparation method thereof |
| 02/11/2009 | CN101361945A Traditional Chinese medicine preparation for treating cardio-cerebrovascular disease |
| 02/11/2009 | CN101361938A Kibe paste containing natural zingiber oil |
| 02/11/2009 | CN101361937A Medicinal pad with antibiosis, itching-relieving, wind-dispelling and dampness-eliminating function |
| 02/11/2009 | CN101361936A Traditional Chinese medicine combination of gynaecologic Shiyang washing lotion and preparation method thereof |
| 02/11/2009 | CN101361920A Traditional Chinese medicine combination of hypotension tranquilization pillow inner |